| Name | Title | Contact Details |
|---|
Private Access, Inc.'s transformative technology platform helps to create an environment of trust by addressing key privacy issues that have impeded the release of data that is otherwise inaccessible, and empowering consumers to establish dynamic privacy directives and consents for both data holders and data seekers
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Ok.net is a San Francisco, CA-based company in the Software and Internet sector.
Model N is the leading provider of Revenue Management and analytics solutions for Life Sciences and High Tech manufacturers. Over 40,000 users across 60 countries, ranging from the Fortune 500 to emerging businesses, use Model N`s business process and analytics solutions delivered in the Cloud or on-premise to align and improve the revenue management process and to gain actionable insights and drive strategic decisions across marketing, sales, and finance.
Software Technology International is a Nashua, NH-based company in the Software and Internet sector.